HIF-1α: A key survival factor for serum-deprived prostate cancer cells
BACKGROUND Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of norm...
Gespeichert in:
Veröffentlicht in: | The Prostate 2008-09, Vol.68 (13), p.1405-1415 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1415 |
---|---|
container_issue | 13 |
container_start_page | 1405 |
container_title | The Prostate |
container_volume | 68 |
creator | Thomas, Rusha Kim, Myoung H. |
description | BACKGROUND
Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells.
METHODS
HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody.
RESULTS
Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival.
CONCLUSION
PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/pros.20808 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2593855</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69441755</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EgrJceACUEwekFG-xYw5IFUuLVAFiEYiL5SQTCKRNsZNCH4sX4ZlwadkuHCxb8jffzPwIbRLcJhjT3ZGtXJviGMcLqEWwkiHGPFpELUwlDjlhcgWtOveIsccxXUYrJI4EkyRqoW7v5Dgk7297QSd4gkngGjsuxqYMcpPWlQ1yfxzYZhBmMLLFGLJg2q42NQSpGaZggxTK0q2jpdyUDjbm9xq6Pj66OuiF_bPuyUGnH6Y8EnGoEoVzLgRhwAVAJgRVmZGKUmmowYYkVCqP5rFiLCbcyMQkiX8ylciUJWwN7c-8oyYZQJbCsLam1H60gbETXZlC__0ZFg_6vhprGikWR5EXbM8FtnpuwNV6ULjpCmYIVeO0UJwT-QnuzMDU7-ss5N9NCNbT3PU0CP2Zu4e3fo_1g86D9gCZAS9FCZN_VPr84uzySxrOagpXw-t3jbFPWkgmI31z2tX9q0N-R89P9S37AMrSngg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69441755</pqid></control><display><type>article</type><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Thomas, Rusha ; Kim, Myoung H.</creator><creatorcontrib>Thomas, Rusha ; Kim, Myoung H.</creatorcontrib><description>BACKGROUND
Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells.
METHODS
HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody.
RESULTS
Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival.
CONCLUSION
PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.20808</identifier><identifier>PMID: 18563715</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - pathology ; Antibodies - pharmacology ; Biomarkers, Tumor - metabolism ; Cell Line, Tumor ; Cell Proliferation ; Cell Survival - physiology ; Cycloheximide - pharmacology ; HIF-1α ; Humans ; Hypoxia - metabolism ; Hypoxia-Inducible Factor 1, alpha Subunit - genetics ; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism ; IGF-2 ; Insulin-Like Growth Factor II - immunology ; Insulin-Like Growth Factor II - metabolism ; Male ; prostate cancer ; Prostatic Neoplasms - metabolism ; Prostatic Neoplasms - pathology ; Protein Synthesis Inhibitors - pharmacology ; RNA, Small Interfering - pharmacology ; Serum Albumin, Bovine - pharmacology ; serum deprivation ; survival ; Up-Regulation ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>The Prostate, 2008-09, Vol.68 (13), p.1405-1415</ispartof><rights>Copyright © 2008 Wiley‐Liss, Inc.</rights><rights>(c) 2008 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</citedby><cites>FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.20808$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.20808$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18563715$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomas, Rusha</creatorcontrib><creatorcontrib>Kim, Myoung H.</creatorcontrib><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>BACKGROUND
Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells.
METHODS
HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody.
RESULTS
Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival.
CONCLUSION
PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - pathology</subject><subject>Antibodies - pharmacology</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Cell Proliferation</subject><subject>Cell Survival - physiology</subject><subject>Cycloheximide - pharmacology</subject><subject>HIF-1α</subject><subject>Humans</subject><subject>Hypoxia - metabolism</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</subject><subject>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</subject><subject>IGF-2</subject><subject>Insulin-Like Growth Factor II - immunology</subject><subject>Insulin-Like Growth Factor II - metabolism</subject><subject>Male</subject><subject>prostate cancer</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Protein Synthesis Inhibitors - pharmacology</subject><subject>RNA, Small Interfering - pharmacology</subject><subject>Serum Albumin, Bovine - pharmacology</subject><subject>serum deprivation</subject><subject>survival</subject><subject>Up-Regulation</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EgrJceACUEwekFG-xYw5IFUuLVAFiEYiL5SQTCKRNsZNCH4sX4ZlwadkuHCxb8jffzPwIbRLcJhjT3ZGtXJviGMcLqEWwkiHGPFpELUwlDjlhcgWtOveIsccxXUYrJI4EkyRqoW7v5Dgk7297QSd4gkngGjsuxqYMcpPWlQ1yfxzYZhBmMLLFGLJg2q42NQSpGaZggxTK0q2jpdyUDjbm9xq6Pj66OuiF_bPuyUGnH6Y8EnGoEoVzLgRhwAVAJgRVmZGKUmmowYYkVCqP5rFiLCbcyMQkiX8ylciUJWwN7c-8oyYZQJbCsLam1H60gbETXZlC__0ZFg_6vhprGikWR5EXbM8FtnpuwNV6ULjpCmYIVeO0UJwT-QnuzMDU7-ss5N9NCNbT3PU0CP2Zu4e3fo_1g86D9gCZAS9FCZN_VPr84uzySxrOagpXw-t3jbFPWkgmI31z2tX9q0N-R89P9S37AMrSngg</recordid><startdate>20080915</startdate><enddate>20080915</enddate><creator>Thomas, Rusha</creator><creator>Kim, Myoung H.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20080915</creationdate><title>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</title><author>Thomas, Rusha ; Kim, Myoung H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4568-9b90f46613e46eed6629da79227a2a0a1b279c45f8933814a7babb33839b7c3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - pathology</topic><topic>Antibodies - pharmacology</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Cell Proliferation</topic><topic>Cell Survival - physiology</topic><topic>Cycloheximide - pharmacology</topic><topic>HIF-1α</topic><topic>Humans</topic><topic>Hypoxia - metabolism</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - genetics</topic><topic>Hypoxia-Inducible Factor 1, alpha Subunit - metabolism</topic><topic>IGF-2</topic><topic>Insulin-Like Growth Factor II - immunology</topic><topic>Insulin-Like Growth Factor II - metabolism</topic><topic>Male</topic><topic>prostate cancer</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Protein Synthesis Inhibitors - pharmacology</topic><topic>RNA, Small Interfering - pharmacology</topic><topic>Serum Albumin, Bovine - pharmacology</topic><topic>serum deprivation</topic><topic>survival</topic><topic>Up-Regulation</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomas, Rusha</creatorcontrib><creatorcontrib>Kim, Myoung H.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, Rusha</au><au>Kim, Myoung H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HIF-1α: A key survival factor for serum-deprived prostate cancer cells</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2008-09-15</date><risdate>2008</risdate><volume>68</volume><issue>13</issue><spage>1405</spage><epage>1415</epage><pages>1405-1415</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>BACKGROUND
Hypoxia‐inducible factor‐1α (HIF‐1α) is commonly overexpressed in prostate cancer (PCa) cells. As PCa cells are known to survive serum deprivation, we investigated the effect of prolonged serum deprivation on HIF‐1α expression, and the function of HIF‐1α in regulating the survival of normoxic serum‐deprived PCa cells.
METHODS
HIF‐1α protein was assessed by immunoblots. Cell viability and proliferation were assessed by trypan blue assay and flow cytometric analysis. Transcriptional activity was assessed by luciferase reporter assay and RT‐PCR. HIF‐1α expression was suppressed with siRNA. Activities of HIF‐1α‐target genes were inhibited with neutralizing antibody.
RESULTS
Prolonged serum deprivation is a potent inducer of HIF‐1α in PC‐3 and LNCaP PCa cells, despite normal oxygen conditions. In contrast, cells grown in the presence of serum did not show HIF‐1α protein accumulation. Moreover, HIF‐1α protein increase during serum deprivation correlated with increased cell survival, while suppression of HIF‐1α expression significantly decreased PCa cell viability. Our results further demonstrate that HIF‐1α protein increase is due to increased HIF‐1α protein synthesis. First, there was no significant increase in HIF‐1α mRNA. Secondly, cycloheximide, a protein synthesis inhibitor, prevented HIF‐1α protein increase in serum‐deprived PCa cells. Moreover, the expression of HIF‐1α‐target genes, VEGF and IGF‐2, was concomitantly increased in serum‐deprived PCa cells, while suppression of HIF‐1α expression significantly inhibited their induction. Furthermore, inhibition of IGF‐2 activity resulted in a significant decline in PCa cell survival.
CONCLUSION
PCa cells counteract the stress of prolonged serum deprivation by upregulating HIF‐1α protein which increases IGF‐2 expression to promote cell survival. Prostate 68: 1405–1415, 2008. © 2008 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>18563715</pmid><doi>10.1002/pros.20808</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0270-4137 |
ispartof | The Prostate, 2008-09, Vol.68 (13), p.1405-1415 |
issn | 0270-4137 1097-0045 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2593855 |
source | MEDLINE; Wiley Journals |
subjects | Adenocarcinoma - metabolism Adenocarcinoma - pathology Antibodies - pharmacology Biomarkers, Tumor - metabolism Cell Line, Tumor Cell Proliferation Cell Survival - physiology Cycloheximide - pharmacology HIF-1α Humans Hypoxia - metabolism Hypoxia-Inducible Factor 1, alpha Subunit - genetics Hypoxia-Inducible Factor 1, alpha Subunit - metabolism IGF-2 Insulin-Like Growth Factor II - immunology Insulin-Like Growth Factor II - metabolism Male prostate cancer Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Protein Synthesis Inhibitors - pharmacology RNA, Small Interfering - pharmacology Serum Albumin, Bovine - pharmacology serum deprivation survival Up-Regulation Vascular Endothelial Growth Factor A - metabolism |
title | HIF-1α: A key survival factor for serum-deprived prostate cancer cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A28%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HIF-1%CE%B1:%20A%20key%20survival%20factor%20for%20serum-deprived%20prostate%20cancer%20cells&rft.jtitle=The%20Prostate&rft.au=Thomas,%20Rusha&rft.date=2008-09-15&rft.volume=68&rft.issue=13&rft.spage=1405&rft.epage=1415&rft.pages=1405-1415&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.20808&rft_dat=%3Cproquest_pubme%3E69441755%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69441755&rft_id=info:pmid/18563715&rfr_iscdi=true |